CS logo
small CS logo
Seirei Mikatahara General Hospital

Hamamatsu, Shizuoka, Japan
浜松市の総合病院

About Seirei Mikatahara General Hospital


社会福祉法人聖隷福祉事業団総合病院聖隷三方原病院は、浜松市北区にある民間の病院である。 2015年3月31日に静岡県から24時間体制で高度な救急医療を行う「高度救命救急センター」に指定された。国や都道府県立、大学附属病院、赤十字などを除く民間で唯一の指定である。 地域医療支援病院や3次救急指定病院にも指定されている。
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Seirei Mikatahara General Hospital


During the past decade, Seirei Mikatahara General Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Seirei Mikatahara General Hospital" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Japan Agency for Medical Research and Development" with 1 trials as a collaborator and "Pharma Valley Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at Seirei Mikatahara General Hospital


According to Clinical.Site data, the most researched conditions in "Seirei Mikatahara General Hospital" are "Coronary Artery Disease" (1 trials), "Idiopathic Interstitial Pneumonia" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Seirei Mikatahara General Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Seirei Mikatahara General Hospital


Most popular intervention types in "Seirei Mikatahara General Hospital" are "Device" (1 trials), "Drug" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Radiation Therapy" (1 trials), "S-1" (1 trials) and "platinum chromium everolimus-eluting stent (PROMUS Element by Boston Scientific, Massachusetts)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Seirei Mikatahara General Hospital


The vast majority of trials in "Seirei Mikatahara General Hospital" are 3 trials for "All" genders.

Clinical Trials Status at Seirei Mikatahara General Hospital


Currently, there are NaN active trials in "Seirei Mikatahara General Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Seirei Mikatahara General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Seirei Mikatahara General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".